ILC1 have been shown to produce TNF-α, an inflammatory cytokine, which is highly elevated in HS skin and a target for biologic HS treatment, our results found no change in the level of ILC1 between the lesional HS skin and healthy control skin. This evidence concerns the gene TNF and histiocytic sarcoma.